Aurora Borealis is a modern indica variety derived from indica parentage. Bred for accessibility and consistency, this strain is well-suited for both indoor and outdoor cultivation environments. Growers can expect a medium yield following a brief flowering period of 53 days, making this an easy-to-manage option for those seeking a reliable harvest.

The chemical profile of Aurora Borealis is defined by a complex arrangement of terpenes, led by the dominance of myrcene, followed by caryophyllene and linalool. These primary compounds are supported by tertiary notes of humulene, ocimene, and nerolidol, which collectively shape the sensory experience of the flower. This specific terpene hierarchy ensures a balanced aromatic and flavorful profile that remains distinct to this modern indica.

As a THC-dominant cultivar, Aurora Borealis is primarily utilized for its ability to induce states of relaxation, calmness, and focused clarity. These effects have established the strain as a practical choice for consumers managing pain, stress, or sleep-related concerns. Beyond its efficacy for individual wellbeing, the strain has demonstrated its genetic value in breeding programs, most notably as a parent to the offspring known as Dank #5.